Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2019-07-29 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
We refer to our letter dated 15th July 2019 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 04.30 ....
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Financial Results for the Quarter and Half Year Ended 30th June 2019' and includes detailed financial data such as revenue, expenses, profit before tax, tax expense, and earnings per share for the quarter and half year periods. It also contains a Limited Review Report from Price Waterhouse & Co Chartered Accountants LLP, indicating that the financial results have been reviewed but not audited. The document references Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The presence of unaudited financial statements and the review report aligns with the characteristics of an Interim / Quarterly Report. The document is substantive and contains actual financial data and analysis, not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2019-07-29 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is an announcement of a corporate action related to share certificates, specifically the issuance of duplicates, and does not contain financial data, management discussion, or report publication. It is not a financial report, earnings release, or management report. It is also not a director's dealing or major shareholding notification. The document is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement to stock exchanges that does not fit other specific categories.
2019-07-26 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate management. The content is about share certificate replacement and does not contain financial data, management discussion, voting results, or other report types. It is an announcement related to share capital but specifically about duplicate certificates, which is a capital-related update but not a new share issue or capital change like stock splits or new issuance. The closest fitting category is Regulatory Filings (RNS) as it is a regulatory compliance announcement that does not fit other specific categories like Share Issue/Capital Change or Director's Dealing.
2019-07-19 English
Updates
Board/Management Information Classification · 95% confidence The document is a notice announcing a meeting of the Board of Directors of Sanofi India Limited scheduled for 29th July 2019 to approve unaudited financial results for the quarter and half year ended 30th June 2019. It provides details about the meeting date, references the financial results to be approved, and directs readers to the company's and stock exchanges' websites for the notice. The document is short (1258 characters) and does not contain actual financial data or detailed financial statements. It is an announcement related to board meeting scheduling and agenda, not the financial report itself. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2019-07-16 English
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.
Regulatory Filings Classification · 95% confidence The document is a notice announcing a Board Meeting scheduled for 29 July 2019 to approve unaudited financial results for the quarter and half year ended 30 June 2019. It includes details about the publication of the notice in newspapers and where it can be accessed online. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short announcement about the meeting and the upcoming approval of financial results, not the financial report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2019-07-16 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled for 29th July 2019. The purpose of the meeting includes consideration of unaudited financial results for the quarter and half year ended 30th June 2019. The document references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain any financial data or detailed report but is an announcement of a meeting where financial results will be considered. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other specific categories like Interim Report or Earnings Release, which require actual financial data or results.
2019-07-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.